Advertisement

Breast Cancer Symposium - Enhancing Clinical Care Through Collaboration

Receptor Status Change after Neoadjuvant Chemotherapy Associated with Improved Relapse-free Survival

A study analyzing receptor change after neoadjuvant chemotherapy (NCT) for patients with ER, PR, and HER2 status breast cancer indicated that receptor status change was associated with improved relapse-free survival, but not overall survival (Abstract 48). Napa Parinyanitikul, MD, presented the results of the study during the Biology in Local/Regional Management Poster Session on Saturday.